Literature DB >> 17710222

DOUBLE TROUBLE IN RECOVERY: SELF-HELP FOR PEOPLE WITH DUAL DIAGNOSES.

Howard S Vogel1, Edward Knight, Alexandre B Laudet, Stephen Magura.   

Abstract

Self-help is gaining increased acceptance among treatment professionals as the advent of managed care warrants the use of cost-effective modalities. Traditional "one disease-one recovery" self-help groups cannot serve adequately the needs of the dually diagnosed. This article discusses Double Trouble in Recovery (DTR), a 12-step self-help group designed to meet the special needs of those diagnosed with both a psychiatric disability and a chemical addiction, DTR differs from traditional self-help groups by offering people a safe forum to discuss their psychiatric disabilities, medication, and substance abuse. Preliminary data collected at four DTR sites in NYC indicate that DTR members have a long history of psychiatric disabilities and of substance abuse, and extensive experience with treatment programs in both areas. They are actively working on their recovery, as evidenced by their fairly intensive attendance at DTR. Recent substance use is limited, suggesting that participation in DTR (in conjunction with format treatment when needed) is having a positive effect. Most members require medication to control their psychiatric disabilities, and that alone may make attendance at "conventional" 12-step groups uncomfortable. Ratings of statements comparing DTR to other 12-step meetings suggest that DTR is a setting where members can feel comfortable and safe discussing their dual recovery needs.

Entities:  

Year:  1998        PMID: 17710222      PMCID: PMC1950134          DOI: 10.1037/h0095288

Source DB:  PubMed          Journal:  Psychiatr Rehabil J        ISSN: 1095-158X


  28 in total

1.  A comparative outcome study of frequent, moderate, occasional, and nonattenders of Alcoholics Anonymous.

Authors:  C G Watson; M Hancock; L P Gearhart; C M Mendez; P Malovrh; M Raden
Journal:  J Clin Psychol       Date:  1997-04

2.  Zealous self-help groups as adjuncts to psychiatric treatment: a study of Recovery, Inc.

Authors:  M Galanter
Journal:  Am J Psychiatry       Date:  1988-10       Impact factor: 18.112

Review 3.  How AA works and why it's important for clinicians to understand.

Authors:  E J Khantzian; J E Mack
Journal:  J Subst Abuse Treat       Date:  1994 Mar-Apr

4.  Length of stay, neuropsychological performance, and aftercare: influences on alcohol treatment outcome.

Authors:  R D Walker; D M Donovan; D R Kivlahan; M R O'Leary
Journal:  J Consult Clin Psychol       Date:  1983-12

5.  Socioathy and drug use in a young psychiatric population.

Authors:  J Westermeyer; V Walzer
Journal:  Dis Nerv Syst       Date:  1975-12

6.  Treatment of patients with psychiatric and psychoactive substance abuse disorders.

Authors:  F C Osher; L L Kofoed
Journal:  Hosp Community Psychiatry       Date:  1989-10

7.  Psychopathology in hospitalized alcoholics.

Authors:  M N Hesselbrock; R E Meyer; J J Keener
Journal:  Arch Gen Psychiatry       Date:  1985-11

8.  Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity.

Authors:  A T McLellan; L Luborsky; G E Woody; C P O'Brien; K A Druley
Journal:  Arch Gen Psychiatry       Date:  1983-06

9.  Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study.

Authors:  B J Rounsaville; T R Kosten; M M Weissman; H D Kleber
Journal:  Arch Gen Psychiatry       Date:  1986-08

Review 10.  Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital.

Authors:  S F Greenfield; R D Weiss; M Tohen
Journal:  Community Ment Health J       Date:  1995-06
View more
  27 in total

1.  Support, mutual aid and recovery from dual diagnosis.

Authors:  A B Laudet; S Magura; H S Vogel; E Knight
Journal:  Community Ment Health J       Date:  2000-10

2.  Predictors of retention in dual-focus self-help groups.

Authors:  Alexandre B Laudet; Stephen Magura; Charles M Cleland; Howard S Vogel; Edward L Knight
Journal:  Community Ment Health J       Date:  2003-08

3.  Perceived reasons for substance misuse among persons with a psychiatric disorder.

Authors:  Alexandra B Laudet; Stephen Magura; Howard S Vogel; Edward L Knight
Journal:  Am J Orthopsychiatry       Date:  2004-07

4.  Social support mediates the effects of dual-focus mutual aid groups on abstinence from substance use.

Authors:  Alexandre B Laudet; Charles M Cleland; Stephen Magura; Howard S Vogel; Edward L Knight
Journal:  Am J Community Psychol       Date:  2004-12

Review 5.  The impact of alcoholics anonymous on other substance abuse-related twelve-step programs.

Authors:  Alexandre B Laudet
Journal:  Recent Dev Alcohol       Date:  2008

Review 6.  Pharmacological treatment of schizophrenia and co-occurring substance use disorders.

Authors:  David A Smelson; Lisa Dixon; Thomas Craig; Stephen Remolina; Steven L Batki; Noosha Niv; Richard Owen
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 7.  12-step participation among dually-diagnosed individuals: a review of individual and contextual factors.

Authors:  Darrin M Aase; Leonard A Jason; W LaVome Robinson
Journal:  Clin Psychol Rev       Date:  2008-05-13

8.  Factors associated with mental health clinicians' referrals to 12-Step groups.

Authors:  Harlan Matusow; Andrew Rosenblum; Chunki Fong; Alexandre Laudet; Thomas Uttaro; Stephen Magura
Journal:  J Addict Dis       Date:  2012

9.  Predictors of motivation for abstinence at the end of outpatient substance abuse treatment.

Authors:  Alexandre B Laudet; Virginia Stanick
Journal:  J Subst Abuse Treat       Date:  2010-02-25

10.  One size fits all: or horses for courses? Recovery-based care in specialist mental health services.

Authors:  Penelope Turton; Alexia Demetriou; William Boland; Stephen Gillard; Michael Kavuma; Gillian Mezey; Victoria Mountford; Kati Turner; Sarah White; Ewa Zadeh; Christine Wright
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-02       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.